News

Researchers at Yale School of Medicine have discovered a new drug compound with the capacity to reverse the brain deficits of Alzheimer’s disease (AD) in an animal model. In this month’s issue of PLoS Biology, in an article entitled, “Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits…

A set of recent studies indicate that the rate of Alzheimer’s disease and other forms of dementia is decreasing in some of the wealthiest nations around the world — including the U.S. According to an article by David Green on The Legacy, research conducted in England,…

A simple test that measures how fast people walk and whether they have cognitive issues can determine how likely they are to develop dementia, which includes diseases such as Alzheimer’s, within 12 years. These are the conclusions of a study led by scientists at the Albert Einstein College of…

Recent results from Prana Biotechnology’s IMAGINE Alzheimer’s trial, released earlier this year (March), as well as the company’s ongoing sub-analysis, has suggested to the company’s research team that further analysis of the PiB-PET Standardized Uptake Value Ratio (SUVR) and the tendency towards preservation of brain volume in PBT2 treated patients may be necessary. The results…

Assertions of a potential link between Lyme disease and Alzheimer’s deaths have been shown baseless by new research at the University of Toronto Mississauga A U of T Mississauga release notes that while researching his book “The Alzheimer’s Epidemic—Searching for Causes and a Cure” (Emeritus Books),…

The onset of Alzheimer’s disease, as well as its symptoms, may be slowed down by a natural compound present in pomegranates, according to research conducted at the University of Huddersfield, in West Yorkshire, UK. During his two-year project, Dr. Olumayokun Olajide, a specialist in anti-inflammatory properties of natural…

A team of researchers who conducted an eight-year study of elderly people believe they have found a relationship between depression and dementia that suggests that treating the first can reduce a part of the effects of the second. The study, published in the journal Neurology, indicates that older people…

Scientists from the Boston University School of Medicine (BUSM) believe they have found modifications in a new gene, PLXNA4, which may be a risk factor in Alzheimer’s Disease (AD) development. According to a recent article on Genetic Engineering News, researchers used data from a previous study, the…

Bioengineers at the University of Washington have designed peptide structures that can neutralize the conversion of a protein from its normal state into an abnormally folded, toxic form, preventing more than 40 amyloid diseases such as Alzheimer’s, Parkinson’s or Type 2 diabetes, for example. Ultimately, this could allow doctors…

A group of scientists is researching the possibility of utilizing a set of compounds developed for cancer treatment as a novel oral therapy for treating Alzheimer’s disease. Up until now, the team had only tested and evaluated injected epothilone D, a brain-penetrant MT-stabilizer, in mice and AD patients. However, in spite of the fact…